Neuroepidemiology plays a crucial role in understanding the distribution, determinants, and outcomes of movement disorders. This track will examine global trends in the prevalence and incidence of Parkinson’s disease, Huntington’s disease, and other movement disorders, focusing on social, environmental, and genetic factors that influence disease development.
Track 20-1: global epidemiology of Parkinson’s disease
Track 20-2: environmental and genetic risk factors
Track 20-3: gender differences in movement disorder prevalence
Track 20-4: epidemiological trends in rare movement disorders
Track 20-5: the impact of public health initiatives on movement disorders
This track will provide valuable insights into the global landscape of movement disorders, highlighting the epidemiological factors that affect their prevalence and progression.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
